Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions

Circulation

Volumn 97, Issue 24, 1998, Pages 2396-2401

  Kastrati, Adnan ^a,b   Schömig, Albert ^a   Elezi, Shpend ^a   Schühlen, Helmut ^a   Wilhelm, Manfred ^b   Dirschinger, Josef ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Lesion; Restenosis; Stents

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RESTENOSIS; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032560648     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.24.2396     Document Type: Article

References (30)

1. Faxon DP. Identifying the predictors of restenosis: do we need new glasses? Circulation. 1997;95:2244-2246.
2. Serruys PW, Foley DP, Kirkeeide RL, King SB III. Restenosis revisited: insights provided by quantitative coronary angiography. Am Heart J. 1993;126:1243-1267.
3. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation. 1993;88:1310-1323.
4. Rensing BJ, Hermans WRM, Vos J, Tijssen JGP, Rutsch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serruys PW. Luminal narrowing after percutaneous transluminal coronary angioplasty: a study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation. 1993;88:975-985.
5. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 1994;90:1239-1251.
6. Violaris AG, Melkert R, Serruys PW. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions: a quantitative angiographic analysis. Circulation. 1995;91:2140-2150.
7. Eeckhout E, van Melle G, Stauffer JC, Vogt P, Kappenberger L, Goy JJ. Can early closure and restenosis after endoluminal stenting be predicted from clinical, procedural, and angiographic variables at the time of intervention? Br Heart J. 1995;74:592-597.
8. Gibson CM, Kuntz RE, Nobuyoshi M, Rosner B, Baim DS. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy: validation of lesion-based restenosis analysis. Circulation. 1993;87:1123-1129.
9. Lehmann KG, Melkert R, Serruys PW. Contributions of frequency distribution analysis to the understanding of coronary restenosis: a reappraisal of the gaussian curve. Circulation. 1996;93:1123-1132.
10. Schömig A, Kastrati A, Elezi S, Schühlen H, Dirschinger J, Dannegger F, Wilhelm M, Ulm K. Bimodal distribution of angiographic measures of restenosis sjx months after coronary stent placement. Circulation. 1997;96:3880-3887.
11. Bresee SJ, Jacobs AK, Garber GR, Ruocco NA Jr, Mills RM, Bergelson BA, Ryan TJ, Faxon DP. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing. Am J Cardiol. 1991;68:1158-1162.
12. Weintraub WS, Brown CL, Liberman HA, Morris DC, Douglas JS Jr, King SB III. Effect of restenosis at one previously dilated coronary site on the probability of restenosis at another previously dilated coronary site. Am J Cardiol. 1993;72:1107-1113.
13. Harrell FE Jr. Predicting Outcomes: Applied Survival Analysis and Logistic Regression. Charlottesville, Va: University of Virginia; 1997.
14. Schömig A, Kastrati A, Mudra H, Blasini R, Schühlen H, Klauss V, Richardt G, Neumann FJ. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation. 1994;90:2716-2724.
15. Black AJR, Namay DL, Niederman AL, Lembo NJ, Roubin GS, Douglas JS Jr, King SB III. Tear or dissection after coronary angioplasty: morphologic correlates of an ischemic complication. Circulation. 1989;79:1035-1042.
16. Hausleiter J, Jost S, Nolte CWT, Dirschinger J, Kastrati A, Stiel GM, Wunderlich W, Fischer F, Linderer T, Hausmann D, Schömig A. Comparative in-vitro validation of eight first- and second-generation quantitative coronary angiography systems. Coron Artery Dis. 1997;8:83-90.
17. Rosner B. Multivariate methods for clustered binary data with more than one level of nesting. J Am Stat Assoc. 1989;84:373-380.
18. Rosner B. Multivariate methods in ophthalmology with application to other paired-data situations. Biometrics. 1984;40:1025-1035.
19. Weintraub WS, Kosinski AS, Brown CL III, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 1993;21:6-14.
20. Carrozza JPJ, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
21. King SB III, Weintraub WS, Tao X, Hearn J, Douglas JS Jr. Bimodal distribution of diameter stenosis 4 to 12 months after angioplasty: implications for definitions and interpretation of restenosis. J Am Coll Cardiol. 1991;17:345A. Abstract.
22. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
23. van Bockxmeer FM, Mamotte CD, Gibbons FA, Taylor RR. Apolipoprotein epsilon 4 homozygosity: a determinant of restenosis after coronary angioplasty. Atherosclerosis. 1994;110:195-202.
24. van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92:2066-2071.
25. Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 1995;43:275-280.
26. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
27. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
28. Violaris AC, Melkert R, Serruys PW. Influence of serum cholesterol subfractions on restenosis after successful coronary angioplasty. Circulation. 1994;90:2267-2279.
29. Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M, Serruys PW. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. Am J Cardiol. 1994;73:50D-61D.
30. Corsini A, Raiteri M, Soma MR, Bernini F, Fumagalli R, Paoletti R. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol. 1995;76:21A-28A.